“Novo Nordisk continues to advance solutions for patients that improve affordability and access to our medicines, whether they have insurance or not. Today, over 55 million people in the U.S. have co… [+10637 chars]Read More
Novo Nordisk introduces NovoCare Pharmacy lowering cost of all doses of FDAapproved Wegovy semaglutide to 499 per month and offering easy home delivery for cashpaying patients PR Newswire
